How III was paid
$11.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Charles Divita, IIIChief executive officer | $800,000 | $9,699,996 | $584,000 | $119,000 | $11,202,996 |
| Mala MurthyFormer chief financial officer | $489,375 | $3,299,998 | $14,000 | — | $3,803,373 |
| Carlos NuenoPresident, international | $589,552 | $2,000,000 | $564,201 | $95,373 | $3,249,126 |
| Kelly BlissPresident, U.S. group health | $516,667 | $2,099,997 | $331,500 | $14,000 | $2,962,164 |
| Adam C. VandervoortChief legal officer and secretary | $495,000 | $2,099,997 | $247,000 | $14,000 | $2,855,997 |
What changed and why
- $11.2MTotal 2025 target compensation for the CEO was $11,202,996.
- 92.9%Equity-based and incentive pay made up 92.9% of the CEO's target compensation.
- 73%Approximately 73% of votes cast supported the 2025 say-on-pay advisory vote.
- $2.5BTotal revenue reached $2.5B alongside $281M in total adjusted EBITDA.
- Stock awards comprised the significant majority of named executive officers' target compensation.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.